Advanced search
Publication Cover
Vascular Health and Risk Management Volume 15, 2019 - Issue
Submit an article Journal homepage
92
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Adherence To Lipid-Lowering Therapy In Patients With Coronary Heart Disease From The State Of Saxony-Anhalt, Germany

Stephan Waßmuth1 Department of Medicine III, University Clinic, Halle, GermanyCorrespondence[email protected]
,
Katharina Rohe1 Department of Medicine III, University Clinic, Halle, Germany
,
Frank Noack2 Emergency Department and Department of Medicine II, University Clinic, Halle, GermanyORCID Iconhttps://orcid.org/0000-0002-6073-7800
ORCID Icon,
Michel Noutsias1 Department of Medicine III, University Clinic, Halle, GermanyORCID Iconhttps://orcid.org/0000-0002-9066-5262
ORCID Icon,
Hendrik Treede3 Department of Cardiac Surgery, University Clinic, Halle, Germany
&
Axel Schlitt4 Paracelsus Harz-Clinic Bad Suderode, Quedlinburg, Germany;5 Medical Faculty, Martin Luther-University Halle-Wittenberg, Halle, Germany
Pages 477-483 | Published online: 31 Oct 2019

References

  • Montalescot G, Sechtem U, Achenbach S, et al. ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949–3003. doi:10.1093/eurheartj/eht29623996286
  • Stang A, Stang M. An inter-state comparison of cardiovascular risk in Germany – towards an explanation of high ischemic heart disease mortality in Saxony-Anhalt. Dtsch Arztebl Int. 2014;530–536.25145511
  • Catapano AL, Graham I, De Backer G, et al. Additional contributor. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999–3058.27567407
  • Kircher T: Hrsg. Medikamentenadhärenz. Kompendium Der Psychotherapie. Berlin, Heidelberg: Springer-Verlag; 2012.
  • Available from: http://apps.who.int/medicinedocs/en/d/Js4883e/6.html Accessed 109, 2019.
  • Mangiapane S, Busse R. Prescription prevalence and continuing medication use for secondary prevantion after myocardial infarction: the reality of care revealed by claims data analysis. Dtsch Arztebl Int. 2011;2011:856–862.
  • Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:772–779. doi:10.1016/j.ahj.2007.12.01118371492
  • Statistisches Bundesamt:2.
  • Grodos G, Tonglet R. Scandinavian simvastatin study (4s). Lancet. 1994;8939–8940.
  • HPSCG. Heart Protection Study Collaborative Group. The Lancet. 2003;2005–2016.
  • Karow T, Lang-Roth R. Allgemeine Und Spezielle Pharmakologie Und Toxikologie [General and special pharmacology and toxicology]. 21. Aufl Köln: Karow; 2012.
  • Spinar J, Spinarova L, Vitovec J. IMProved reduction of outcomes: vytorin Efficacy International Trial (studie IMPROVE-IT). Vnitr Lek. 2014;60:1095–1101.25692840
  • Deshpande S, Quek RG, Forbes CA, et al. A systematic review to assess adherence and persistence with statins. Curr Med Res Opin. 2017;33:4. doi:10.1080/03007995.2017.1301903
  • National Institute for Health and Clinical Excellence: Guidance. BLipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease; 2014.
  • Pittman DG, Chen W, Bowlin SJ, et al. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107:1662–1666.21439533
  • Chen ST, Huang ST, Shau WY, et al. Long term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease. BMC Cardiovasc Disord. 2019;19:1. doi:10.1186/s12872-019-1032-430606129
  • Maciej B, Stulc T, Dent R, Toth PP. Statin non adherence and cardiovascular risk: there is need for substantial improvement. Int J Cardiol. 2016;225:184–196. doi:10.1016/j.ijcard.2016.09.07527728862
  • Griffiths B, Lesosky M, Ntsekhe M. Self-reported use of evidence-based medicine and smoking cessation 6–9 months after acute coronary syndrome: a single-centre perspective. S Afr Med J. 2014;104:483–487. doi:10.7196/samj.779825214049
  • Lemstra M, Blackburn D. Nonadherence to statin therapy: discontinuation after a single fill. Can J Cardiol. 2012;28:567–573. doi:10.1016/j.cjca.2012.03.01822658124
  • Kim MC, Cho JY, Jeong HC, et al. Impact of Postdischarge Statin Withdrawal on Long-Term Outcomes in Patients With Acute Myocardial Infarction.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.